author-photo

Gerald Hall

Eli Lilly and Company

19

Papers

233

Citations

Citation Trend

Filter By

Papers (19) Sort By

JournalConferenceOthers

Effects of prexasertib, a CHK1 inhibitor, in the immune microenvironment of head and neck squamous cell carcinoma (HNSCC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3945: The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy via immunogenic tumor cell death and T cell-intrinsic mechanisms

2019 Immunology
Show All
- Source
- Cite
- Save
Citations (2)
The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (42)
Abstract A160: Combination of necitumumab with second- or third-generation EGFR tyrosine kinase inhibitors downregulates DNA repair mechanisms and induces durable tumor remissions in xenograft NSCLC models with EGFR mutations

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4549: Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Abstract B108: Antitumor efficacy of EGFR antibody necitumumab and dual PI3K/mTOR inhibitor (LY3023414) in preclinical tumor models

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3632: Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

2018 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
P1.04-07 Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号